• A capillary electrophoresis procedure for the screening of oligosaccharidoses and related diseases
• Active-site motifs of lysosomal acid hydrolases: invariant features of clan GH-A glycosyl hydrolases deduced from hydrophobic cluster analysis
• Adult leukoencephalopathy caused by alpha-mannosidosis deficiency
• Alpha-Mannosidosis
• alpha-Mannosidosis in the guinea pig: cloning of the lysosomal alpha-mannosidase cDNA and identification of a missense mutation causing alpha-mannosidosis
• Analysis of urinary oligosaccharide excretion patterns by UHPLC/HRAM mass spectrometry for screening of lysosomal storage disorders
• Apparently normal extracellular acidic alpha-mannosidase in fibroblast cultures from patients with mannosidosis
• Biochemical characteristics of point mutated Capra hircus lysosome α-mannosidase
• Bone marrow transplantation for the treatment of alpha-mannosidosis
• Chemistry of urinary mannosides excreted in mannosidosis
• Correction of I-cell defect by hybridization with lysosomal enzyme deficient human fibroblasts
• Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study
• Elevated Dipeptidyl Peptidase IV (DPP-IV) Activity in Plasma from Patients with Various Lysosomal Diseases
• Enzymological diagnosis of a group of lysosomal storage diseases. Review of 5-year experience of 1600 patient-sample referrals
• Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals
• Immune system irregularities in lysosomal storage disorders
• In utero transplantation of monocytic cells in cats with alpha-mannosidosis
• Intestinal Epithelial Cell-specific Deletion of α-Mannosidase II Ameliorates Experimental Colitis
• Lysosomal storage diseases in Greece
• Mannosidosis type II
• Missense and nonsense mutations in the lysosomal alpha-mannosidase gene (MANB) in severe and mild forms of alpha-mannosidosis
• Mortality in patients with alpha-mannosidosis: a review of patients' data and the literature
• Mucolipidosis type I. Sialidosis due to alpha-2-6-neuraminidase deficiency with neurological symptoms
• Neurological presentations of lysosomal diseases in adult patients
• Neutral alpha-mannosidase activity in human serum
• Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis
• Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults
• Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice
• Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase
• Sphingomyelin lipidosis in a cat: Golgi studies
• Storage of mannose-containing material in cultured human mannosidosis cells and metabolic correction by pig kidney alpha-mannosidase
• Survival and engraftment of mouse embryonic stem cell-derived implants in the guinea pig brain
• The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes
• The clinical and pathologic heterogeneity of feline alpha-mannosidosis
• Unmanipulated HLA-haploidentical bone marrow transplantation for the treatment of fatal, nonmalignant diseases in children and adolescents